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People with epilepsy receiving renal 
replacement therapy with hemodialysis
Scientists recall progress and promise of translational research
Fulvio A. Scorza1, Ricardo M. Arida2, Vera C. Terra3, Rui Alberto Gomes4, Esper A. Cavalheiro1
Opinion
Nowadays, we have observed that discoveries in med-
ical sciences have rapidly accelerated and continue to ex-
pand. One of the reasons for these positive recent chang-
es is due to the onset of translational research. The term 
translational research, which was recently incorporated 
in the dictionary of medical sciences, indicates the inte-
gration of the advancements in basic science with clini-
cal trials, taking research from the “bench-to-bedside”1. 
This perspective gives rise to a completely new approach 
to improving health care for people with chronic dis-
eases. Following this line of thought, we currently know 
that this scientific convergence works very well in sever-
al fields1, but can still be considered rare among nephrol-
ogists and neurologists. Evaluating the field of nephrol-
ogy, the chronic renal failure, a progressive loss of kid-
ney function that results in permanent kidney failure, is 
a worldwide public health problem. Furthermore, indi-
viduals in this condition need dialysis or a transplanted 
kidney. Even more problematic than these aspects, renal 
failure is associated with an increased risk of cardiovas-
cular disease and sudden death2. Now, looking through 
the prism of Neurology, we know that epilepsy is consid-
ered the most common serious neurological condition. 
Unfortunately, each year about one in a 1000 patients 
with chronic epilepsy will die suddenly, unexpectedly, 
and without explanation, even with post-mortem exami-
nation3. Among neurologists around the world, this phe-
nomenon is called sudden unexplained death in epilep-
sy (SUDEP). In the actual scenario, epilepsy is associated 
with a two- to three-fold increase in mortality compared 
to the general population, and SUDEP is the most impor-
tant direct epilepsy-related cause of death3. Thus, as these 
two chronic diseases are very common in the world and 
also a global public health problem, a new line of trans-
lational research would have great value in helping neu-
rologists and nephrologists to investigate what would be 
the best strategy to be drawn if these two chronic diseas-
es involve the same individual. From this perspective and 
mainly due lack of data in the world, our research group 
decided to investigate the possible relationship between 
seizure frequencies in patients with end-stage renal dis-
ease (ESRD) under regular dialysis program4. Briefly, from 
189 ESRD patients, 7 had suffered some type of convul-
sive seizure during dialytic program4. At that time, we 
concluded that despite the occurrence of seizures is con-
sidered rare among ESRD individuals receiving dialysis, 
it should be apparent that a true convergence of clinical 
nephrology and neurology should always be part of this 
scenario4. The next step for the researchers of our Insti-
tute of Nephrology was to verify the possible association 
between epilepsy and hence SUDEP in these individuals5. 
Overall, we noted in all the cases evaluated (7 out of 209) 
that cardiovascular abnormalities and hence SUDEP is a 
rare event in ESRD people with epilepsy receiving dialy-
sis5. Although these data have to be interpreted with cau-
tion due to a small number of cases examined, we contin-
ue to believe that the flame of translational science among 
professionals directly involved with these patients must 
be permanently lit.
In sum, it has been repeatedly and firmly established 
in medical literature that chronic diseases, epilepsy and 
chronic renal insufficiency in this particular case, have ex-
traordinarily high mortality rates and dialysis people and 
individuals with epilepsy are at increased risk of sudden 
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cardiac death in general. In this sense, while the trans-
lational science developed between nephrologists and 
neurologists is unable to prevent the installation of these 
illnesses or even completely reverse the clinical picture 
when both are already installed, some preventive strate-
gies (already established in the literature for the situations 
mentioned here)6-9 should be part of clinical routine of 
these professionals and obviously adhered to by patients 
in order to prevent the occurrence of cardiovascular ab-
normalities and hence sudden cardiac death: [1] main-
tain a healthy weight, consume a healthy and balanced 
diet, avoid smoking, and consume a limited amount of 
alcohol; [2] maintain a regular practice of physical activ-
ity under the supervision of a qualified professional; [3] 
establish a diet with omega 3 fatty acids from fish or fish 
oil supplements is strongly recommended; [4] maintain 
a good quality of sleep; [5] manage stress by changing the 
way you respond to stress, making time for relaxation, 
and learning healthier coping strategies.
Finally, trying to solve these considerations is never 
an easy task; nephrologists and neurologists should real-
ly start thinking of a way translational and have to keep 
in mind that is time to establish a task force to assess the 
state of knowledge (clinical management, research direc-
tions, and educational, social and cultural efforts). As ev-
ery journey begins with the first step, draws up a list of all 
the current problems present and evaluates which ones 
merit fixing and which ones are actually fixable should 
provide a promising future.
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